a b s t r a c t 3 -Deoxy-3 -fluorothymidine (FLT, alovudine ® ) belongs to the most potent agents inhibiting HIV-1 replication. Its 5 -triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse transcriptase (HIV RT). Unfortunately, FLT exerts substantial hematologic toxicity both in vitro and in vivo. It was suggested that this toxicity may be related to inhibition of human DNA polymerases, especially mitochondrial DNA polymerase ␥, by nucleoside analogue 5 -triphosphates leading to termination of DNA synthesis and mitochondrial dysfunction. To decrease the toxicity of FLT, its thiated analogues, 4-SFLT and 2-SFLT, were previously synthesized and shown to be potent inhibitors of HIV-1 with low in vitro cytotoxicity. To explain this phenomenon in the present study the synthesis of 5 -triphosphates of thiated FLT analogues was undertaken and their interaction with recombinant HIV-1 RT and human DNA polymerases ␥ (pol ␥) and ␤ (pol ␤) was investigated. It was shown that 3 -deoxy-3 -fluoro-4-thiothymidine 5 -triphosphate (4-SFLTTP) and 3 -deoxy-3 -fluoro-2-thiothymidine 5 -triphosphate (2-SFLTTP) were, similarly to FLTTP, potent competitive inhibitors of HIV-1 RT, with K Of special interest is that 2-SFLTTP, showing syn conformation, is a less potent inhibitor of human mitochondrial pol ␥ than 4-SFLTTP and FLTTP, both in the anti conformation, and has a higher inhibitory activity against HIV-1 RT than 4-SFLTTP. Moreover, the parent nucleoside 2-SFLT possessing the syn conformation shows a more potent anti-HIV-1 activity and a better selectivity index than its 4-thio isomer in the anti conformation (Matthes et al., 1989; Poopeiko et al., 1995) , 2-SFLT is a potent and selective anti-HIV-1 agent with the selectivity index 4-fold higher than that of FLT.
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Findings regarding the mechanisms of antiviral and cytotoxic activities of FLT and its thioanalogues are discussed.
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Introduction
Multidrug, highly active antiretroviral therapy (HAART) employed in the treatment of human immunodeficiency virus (HIV) infection uses as its main components nucleoside inhibitors of HIV reverse transcriptase (NRTIs). It was suggested that long term therapy with the NRTIs may be associated with mitochondrial DNA polymerase ␥ (pol ␥) inhibition and subsequent depletion of mitochondrial DNA (Kaguni, 2004; Kakuda, 2000) . However, the DNA pol ␥ hypothesis by itself fails to explain the entire array of metabolic deficiencies associated with NRTI-induced disorders. Direct effects of NRTI's on various mitochondrial targets must also be taken into account (Lund and Wallace, 2004) .
3 -Deoxy-3 -fluorothymidine (FLT, alovudine ® ) belongs to the most potent agents inhibiting HIV-1 replication. In addition, it is highly active against HIV-1 multidrug resistant (MDR) strains. Its 5 -triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse transcriptase (HIV RT, RNA-directed DNA polymerase, EC 2.7.7.49) (Cheng et al., 1987) . Unfortunately, FLT displays high cytotoxicity against host cells which limits its clinical applicability (Balzarini et al., 1988) . It was suggested that this toxicity may be related to inhibition of human DNA polymerases (EC 2.7.7.7), especially mito-chondrial DNA polymerase ␥, by FLT metabolite-5 -triphosphate, leading to termination of DNA synthesis and mitochondrial dysfunction (Kaguni, 2004) . To decrease the cellular toxicity of FLT, its thiated analogues 4-SFLT and 2-SFLT were previously prepared and shown to be potent in vitro inhibitors of HIV-1 with low toxicity (Matthes et al., 1989; Poopeiko et al., 1995) . To establish whether inhibition of pol ␥ exerted by thiated FLTTP analogues is correlated with development of in vitro cytotoxicity in cell cultures, we decided to synthesise 2-SFLTTP, 4-SFLTTP as well as FLTTP and to investigate their interactions with recombinant HIV-1 RT and human polymerases ␥ and ␤.
Materials and methods

Chemicals
[Methyl-3 H] dTTP (45.9 Ci/mmol) was purchased from Moravek Biochemicals Inc., Brea, CA; nucleotides and activated calf thymus DNA were from Sigma; AZTTP was purchased from Calbiochem; poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] and HIV reverse transcriptase were from GE Healthcare (Amersham Biosciences); DE81 (2.3 cm) circles were from Whatman. Triton X-100 and rotiszint eco plus LSC-universal cocktail were from Roth. Recombinant human DNA polymerases ␥ and ␤ were provided by EURx Ltd. (Gdańsk, Poland). All other reagents used in this study were of analytical grade.
Synthesis of thiated nucleoside 5 -triphosphates
The syntheses of 5 -triphosphates of 2-SFLT, 4-SFLT as well as FLT (Fig. 1) were performed with the use of modified Vrang procedure (Vrang et al., 1987) employing direct phosphorylation of unprotected nucleosides.
Assays of HIV-1 reverse transcriptase and human DNA polymerases andˇactivities
The activities of HIV-1 RT and both human polymerases were assayed by DE81 filter isotopic method (Reardon and Miller, 1990) . Unless otherwise indicated, reaction mixtures for RT activity studies contained 50 mM KCl, 50 mM Tris-HCl, pH 7.8, 13 mM sodium phosphate buffer, pH 7.0, 10 mM MgCl 2 , 0.02% Triton X-100, 0.33 mM DTT, 20 M [ 3 H]dTTP (128-180 DPM/pmol), 9 g/ml poly(rA)·p(dT) 12-18 and 14 ng HIV reverse transcriptase. Reaction mixture for pol ␥ contained 25 mM HEPES-KOH (pH 8.0), 5 mM Tris-HCl (pH 8.0), 0.25 mM DTT, 0.5 mM MnCl 2 , 2.5 mM ␤-ME, 10 g acetylated BSA, 0.01% Triton X-100, 5 M [ 3 H]dTTP (4 × 10 3 DPM/pmol), 0.1 M NaCl, 20 g/ml poly (rA)·oligo(dT) [12] [13] [14] [15] [16] [17] [18] and 98 ng of polymerase ␥. Reaction mixture for pol ␤ contained 50 mM Tris-HCl (pH 7.8), 10 mM MgCl 2 , 0.4 mg/ml of BSA, 2.5 mM DTT, 100 mM KCl, 5 mM NaCl, 0.01% Triton X-100, 50 M dNTP (specific activity of [ 3 H]dTTP was 2 × 10 2 DPM/pmol), 300 g/ml activated calf thymus DNA and 18 ng of polymerase ␤. All the reaction mixtures were initiated with enzyme in a total volume of 20-30 l and incubated at 37 • C and performed for 30 min. 10-15 l of a reaction mixture was spotted onto DE81 (2.3 cm) paper circle. In order to remove unincorporated [ 3 H]dTTP, the circles were washed 3× with 5% Na 2 HPO 4 , 3× with distilled water and once with 95% ethanol. After placing the dry circles in scintillation flasks, 300 l of the elution mixture (0.2 M KCl, 0.1 M HCl) was added. The amount of [ 3 H]dTMP incorporated into template and adsorbed on the circle was determined in scintillation cocktail using a PerkinElmer ® scintillation counter.
Steady-state kinetic assays
The appropriate concentrations of each inhibitor used for the K app i determination were calculated using the Cheng and Prusoff equation
where [S] and K m were the concentration and affinity of the radioligand, respectively (Cheng and Prusoff, 1973) .
values for HIV-1 RT inhibition were determined at minimum two concentrations of each compound tested and four concentrations of dTTP in the range of 1-32 M and at saturating poly(rA)·p(dT) 12-18 concentration of 9 g/ml. K app i values for human pol ␥ inhibition were determined at two to three concentrations of each inhibitor tested and four concentrations of dTTP in the range of 1.5-12 M and at saturating poly(rA)·p(dT) 12-18 concentration of 20 g/ml. K app i values for human pol ␤ inhibition were determined at two concentrations of each inhibitor tested and four concentrations of dTTP in the range of 40-320 M and saturating concentration of activated calf thymus DNA of 300 g/ml. V values were calculated using nonlinear regression by fitting of the experimental data to the appropriate equations in GOSA fit (Global Optimization by Simulated Annealing) Bio-Log software. To determine the type of inhibition, the experimental data were fitted to the general equation for reversible inhibition in GOSA fit, and, additionally, the double-reciprocal plots of dTMP incorporation rate into template-primer and dTTP concentration dependence in the presence of several inhibitor concentrations (Lineweaver-Burk plots) were generated.
NMR-based conformational analysis
All the spectra of nucleoside 5 -triphosphates and the corresponding nucleosides were recorded for their aqueous solutions at 298 K on 500 MHz Varian Unity Plus spectrometer. The spectra were processed with the aid of MestRec 4.56 using /4 shifted sine-bell filter followed by Lorenzian smoothing resulting in 0.5 Hz line broadening and zero-filling up to 32k data points prior to Fourier transformations. The resonance signals of nucleosides were assigned on the basis of the geminal and vicinal scalar couplings extracted from the spectra and verified by comparison of the simulated and experimental spectra. The assignment of those of triphosphates was adopted from the spectra of the corresponding nucleosides. Due to significant broadening of the resonance lines, no furanose ring puckering analysis could have been applied for nucleoside 5 -triphosphates, and only syn-anti preferences about the glycosidic bond were followed by the analysis of the two proposed discriminators-e.g., chemical shift of H1 and the separation of H2 and H2 resonances, both of which were previously proven sensitive to relative orientation of ribose and pyrimidine moieties (Poznański et al., 2000) .
Results and discussion
Kinetics of incorporation of dTMP
The rates of dTMP incorporation into poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] by HIV-1 RT and human DNA polymerase ␥ and into activated DNA by human DNA pol ␤ were linear with respect to time and enzyme concentration with V app max values of 370 ± 99, 0.23 ± 0.05 and 64 ± 15 nmol min −1 mg −1 protein, respectively; the template-primer concentrations used in the assays did not inhibit the enzyme activity (Majumdar et al., 1988) . The K app m value obtained for dTTP for HIV-1 RT (9.05 ± 0.46 M) was similar to the values determined by others with the use of poly(rA)·p(dT) 12-18 (Matthes et al., 1989; Reardon and Miller, 1990) , whereas K app m values for the substrate obtained for the studied recombinant human DNA polymerases ␥ and ␤ (2.61 ± 0.19 M and 78 ± 14 M, respec- tively) were significantly higher than those reported for the native polymerases isolated from mammalian cells and assayed with the use of the same template-primers as in the present study (Faraj et al., 2000; Hart et al., 1992; Martin et al., 1994) . However, the observed difference between the K app m values for dTTP for both polymerases studied was similar to that demonstrated by others, and the low K app m for pol ␥ was diagnostic for this polymerase (Hart et al., 1992; Martin et al., 1994) .
Effects of 4-SFLTTP and 2-SFLTTP on HIV-1 reverse transcriptase and human DNA polymerases andF
LTTP and AZTTP were used in the present study as controls in HIV-1 RT and human DNA polymerases inhibition assays. The results obtained for inhibition of HIV-1 RT and human polymerase ␥ and ␤ by the tested compounds are presented in Table 1 . Enzyme kinetic studies with HIV-1 RT (Lineweaver-Burk plots) showed that both 4-SFLTTP and 2-SFLTTP were, similarly to the parent compound and to AZTTP, competitive inhibitors of this enzyme with respect to dTMP incorporation into poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] . K app i values for both control inhibitors for HIV-1 RT inhibition with poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] were within the range of values reported in the literature (Cheng et al., 1987; Hart et al., 1992; Matthes et al., 1990; Reardon and Miller, 1990) . 4-SFLTTP was about three and four times less inhibitory to HIV-1 RT than FLTTP and AZTTP, respectively (Table 1 ). In contrast, 2-SFLTTP exhibited exactly the same inhibitory effect toward HIV-1 RT as AZTTP and slightly greater than FLTTP. The obtained difference between the activity of 4-SFLTTP and the parent compound, FLTTP, toward HIV-1 RT was in agreement with the results previously reported (Matthes et al., 1989) .
4-SFLTTP and 2-SFLTTP were found to be effective inhibitors of human DNA polymerase ␥. Interestingly, 2-SFLTTP acted as an uncompetitive inhibitor of this polymerase with respect to dTMP incorporation into poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] (Fig. 2A) , whereas 4-SFLTTP inhibited this enzyme similarly to FLTTP, i.e., non-competitively (Fig. 2B) . AZTTP was found to be a mixed inhibitor of human DNA pol ␥ with respect to dTMP incorporation into poly(rA)·p(dT) 12-18 , with both competitive and uncompetitive mechanisms of inhibition operating with different K values was reported by others, when poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] was used as the template-primer for mitochondrial polymerase (Lewis et al., 1994) . The presented data indicate that 4-SFLTTP, similarly to control inhibitors, FLTTP and AZTTP, can bind both the free enzyme and the enzyme-substrate complex, but unlike AZTTP, binds with the same affinity, whereas 2-SFLTTP binds only the enzyme-substrate complex. The obtained results are rather intriguing and difficult to explain, however, lack of recognition of studied compounds as thymidine analogues by pol ␥ might be important reason, that inhibition is not competitive with respect to dTTP. It was demonstrated that AZTTP was noncompetitive inhibitor of HIV RT with respect to other nucleotides than dTTP (König et al., 1989) . In the case of 2-SFLTTP, it could be possible, that its syn conformation contributed to the untypical mechanism of inhibition. Furthermore, the influence of some physico-chemical properties of studied recombinant pol ␥ (number of free -SH or lack of some posttranslational modifications) or/and additionally template dependence may be also taken into consideration. It is noteworthy that 2-SFLTTP in contrast to FLTTP and 4-SFLTTP (no selectivity was observed) was several fold more selective toward HIV-1 RT than toward human pol ␥, although, it was less selective than AZTTP (Table 1) . In comparison to FLTTP and its thionucleotides, AZTTP was found in the present study to be a relatively weak inhibitor of human DNA pol ␥, which is consistent with the literature data demonstrating inhi- bition of this polymerase by AZTTP and other ddNTP (Hart et al., 1992; Martin et al., 1994; Parker et al., 1991) . The results obtained for human pol ␥ inhibition were in agreement with other studies demonstrating that human DNA pol ␥ is unique among the cellular replicative DNA polymerases in that it is highly sensitive to inhibition by anti-HIV nucleotide analogues (Johnson et al., 2001; Lee et al., 2003; Lim and Copeland, 2001; Martin et al., 1994; Parker et al., 1991) . It was demonstrated that mitochondrial polymerase readily incorporated 2 ,3 -dideoxy-CTP (ddCTP), 2 ,3 -dideoxy-ITP (ddITP) and 2 ,3 -didehydro-3 -deoxy-TTP (D4T-TP) with an efficiency similar to the incorporation of normal nucleotides, whereas AZTTP, carbocyclic 2 ,3 -didehydroddGTP (CBV-TP) and (−)-2 ,3 -dideoxy-3 -thiacytidine-TP (3TC-TP) acted as only moderate inhibitors of this enzyme (Bienstock and Copeland, 2004; Eriksson et al., 1995; Hanes and Johnson, 2008; Lim and Copeland, 2001) .
Enzyme kinetic studies with human DNA pol ␤ demonstrated that both 4-SFLTTP and 2-SFLTTP, similarly to AZTTP and FLTTP were competitive inhibitors of that enzyme with respect to dTMP incorporation into activated DNA. The data obtained for inhibition of pol ␤ by 4-SFLTTP and FLTTP were consistent with the previously reported results, demonstrating 4-SFLTTP to be less effective than FLTTP (Matthes et al., 1987 (Matthes et al., , 1989 ). The reported K app i values for AZTTP inhibition of dTMP incorporation into endonucleaseactivated DNA vary for this polymerase between 0.67 and 810 M. The reason for this dramatic disparity is not clear. However, AZTTP in the most cases was a less potent inhibitor of polymerase ␤ than the ddNTPs (Copeland et al., 1992; Hart et al., 1992; Martin et al., 1994) . In the present study, AZTTP was found to be an over 100-fold less potent inhibitor of human pol ␤ than FLTTP, which is in agreement with the literature data (Martin et al., 1994) . The observed general inhibitory effect of the studied compounds was reported for other NRTIs (Kakuda, 2000) , with the following hierarchy: HIV-1 RT > human pol ␥ > human pol ␤, with the exception of 4-SFLTTP (higher K app i for HIV-1 RT than for pol ␥).
NMR-based conformational analysis
The different interaction of the 2-and 4-thio FLTTP analogues with polymerase ␥ is intriguing and may be due to the different, unusual syn conformation around the glycosidic bond of the 2-thio FLT analogues (Fig. 1A) , in contrast to FLT itself and to its 4-thio analogue which show typical for natural nucleosides conformation anti (Fig. 1B) . This was more precisely analysed with the aid of NMR spectroscopy. The resonance assignment is summarised in Table 2 . On the basis of the data obtained previously for a series of variously substituted ␣ and ␤ 2 -deoxyuridine derivatives (Remin, 2001) , we have previously found that the separation of 2 ,2 methylene group resonances is indicative of a syn-anti equilibrium. Consequently, the data presented in Fig. 3 clearly indicate that FLT, FLTTP, 4-S-FLT, 4-S-FLTTP and dUrd are in an anti conformation, while in their 2-S substituted derivatives, 2-S-FLT, 2-S-FLTTP, 2,4-S-FLT, 2,4-S-FLTTP and 2-S-dUrd the syn conformation predominates (Fig. 3) .
Inhibition of enzymes versus in vitro anti-HIV-1 activity of 4-SFLT and 2-SFLT
The presented results do not show much correlation with the anti-HIV-1 in vitro studies on syncytia-inducing laboratory HIV-1 strain in MT-4 cells, which demonstrate that 2-SFLT and 4-SFLT inhibit viral growth with EC 50 of 0.269 and 1.0 M (Table 1) , respectively, with very low cytotoxicity observed (CC 50 of 223 and 480 M, respectively) (Matthes et al., 1989; Poopeiko et al., 1995) . 2-SFLT and 4-SFLT were several orders of magnitude weaker inhibitors of HIV replication than FLT (EC 50 0.001 M) (Balzarini et al., 1989) , whereas K app i values obtained for the inhibition of HIV-1 RT by their triphosphates were comparable and 3-fold higher than that for FLTTP, respectively (Table 1) . However, it is noteworthy that 4-SFLTTP was a nearly 4-fold weaker inhibitor of HIV-1 RT than 2-SFLTTP, and a similar relation between EC 50 values for the adequate thionucleosides was observed in in vitro anti-HIV-1 activity studies (Matthes et al., 1989; Miazga et al., 2003; Poopeiko et al., 1995) .
There was no correlation between the obtained K app i
values for human pol ␥ and pol ␤ inhibition by 5 -triphosphates of FLT and its two thionucleosides (Table 1 ) and the cytotoxicity observed in in vitro tests. 4-SFLT and 2-SFLT exerted very low cytotoxicity in comparison to FLT (CC 50 of 480, 223 and 0.197 M, respectively) (Balzarini et al., 1989; Matthes et al., 1989; Poopeiko et al., 1995) . The above results are in contrast to the observation that 4-SFLTTP and 2-SFLTTP inhibit pol ␥ similarly and only 4-fold less than FLTTP, respectively, and, moreover, 1-2 orders of magnitude more strongly than AZTTP (Table 1) . On the other hand, AZT exerts much stronger cytotoxicity than thionucleosides with CC 50 = 4.81 M (Balzarini et al., 1989) . Furthermore, both thionucleoside 5 -triphosphates were found to be much more effective inhibitors of human DNA pol ␤ than AZTTP, but, respectively comparable and 6-fold less effective inhibitors of DNA pol ␤ in the case of 2-SFLTTP and 4-SFLTTP as compared to FLTTP (Table 1 ). The data on pol ␥ inhibition are in line with previous results, obtained with other nucleoside analogues, which point to the lack of a universal mechanism of mitochondrial toxicity exerted by NRTIs (Lund and Wallace, 2004; Lund et al., 2007) . The poor correlation between inhibition of HIV-1 RT and human DNA polymerases and the effects in cells was observed for many other NRTIs including analogues of thymidine triphosphate, such as ddTTP and d4TTP (Martin et al., 1994) . Obviously, a precise correlation between enzyme inhibition and the effects on cells cannot be expected, because of numerous differences in the assays. The templates and primers used in the present study, poly(rA)·p(dT) [12] [13] [14] [15] [16] [17] [18] and activated calf thymus DNA, were artificial and differed from those the enzymes might encounter in HIV-1 infected cells. Different templates and primers will give rise to binary enzyme-template and primer complexes whose interactions with a particular nucleotide might result in significantly different K app i values (Hart et al., 1992) . Many processes of intracellular metabolism of nucleoside analogues, like reduction, oxidation, glycosylation and phosphorylation of nucleosides in cells, can influence the anti-HIV activity and cytotoxicity of NRTIs (Becher et al., 2003; Lund et al., 2007; Steet et al., 2000) . It was demonstrated that hematopoietic toxicity of FLT in vivo was due in part to its efficient conversion to FLTTP and that FLT induced both damage and apoptosis in human lymphoblastoid cell line (Sundseth et al., 1996) . Several physico-chemical effects, like a decrease in the pK a values for dissociation of N(3)-H or an increase in the hydrophobic properties of the pyrimidine moiety due to the presence of a sulphur atom, can affect the cell membrane interactions and transport of nucleoside analogues into the mitochondria; this would influence the anti-HIV activity and cytotoxicity of 4-SFLT and 2-SFLT (Stahle et al., 1993) . Moreover, a decrease in the pK a values for dissociation of N(3)-H in both 2-SFLT and 4-SFLT as compared to FLT can reduce the phosphorylation efficiency of the thionucleosides by cellular and mitochondrial kinases, thus weakening their cytotoxicity. It was demonstrated that while both HIV-1 RT and human pol ␥ exhibit 5 -to-3 DNA polymerase activity, only DNA pol ␥ has an intrinsic 3 -to-5 exonuclease proofreading activity, which can reduce the toxicity by removal of nucleoside analogues from DNA termini. Moreover, the rates of the exonuclease excision of different NRTIs by mitochondrial DNA pol ␥ were found to vary significantly (Graves et al., 1998; Hanes and Johnson, 2008; Lee et al., 2003; Lim and Copeland, 2001; Longley et al., 1998) . The presence of a sulphur atom in the pyrimidine moiety may affect the exonuclease efficiency of polymerase ␥ for both thionucleosides by destabilising binding at the polymerase site (Hanes and Johnson, 2008) .
It is worth to notice, that besides examined in this work host polymerases, other cellular polymerases also exposed to triphosphate forms of tested thymidine analogues are potential targets for cytotoxicity. However, Matthes et al. demonstrated poor sensitivity of polymerase ␣ for both 4-SFLTTP and FLTTP with IC 50 values of 140 M and above 200 M, respectively (Matthes et al., 1987 (Matthes et al., , 1989 . Additionally, many other inhibition studies showed that polymerase ␣ was less sensitive to other thymidine nucleotide analogues than polymerase ␥ and mostly similarly or even less sensitive to such compounds than polymerase ␤ (Faraj et al., 2000; Hart et al., 1992; Martin et al., 1994; Matthes et al., 1987) . Moreover, it was demonstrated, that both polymerase and polymerase ␦ with IC 50 values for FLTTP over 100 M and 200 M, respectively (von Janta-Lipinski et al., 1998), likewise polymerase ␣, were mainly less sensitive to thymidine nucleotide analogues than both polymerases ␥ and ␤ (Focher et al., 1995; Huang et al., 1992; Martin et al., 1994; Yang et al., 2007) .
Conclusions
The presented results show that both 4-SFLTTP and 2-SFLTTP are potent, competitive inhibitors of HIV-1 RT. On the other hand, their parent nucleosides, 4-SFLT and 2-SFLT exert reduced, in comparison to FLT, anti-HIV-1 activity as well as cytotoxicity, in spite of the high inhibitory activities of their 5 -triphosphates against human polymerase ␥ (Table 1) . Anti-HIV-1 RT inhibitory activities of 5 -triphosphates of both thiated nucleoside analogues only partially correlated with the antiviral activities of their parent nucleosides.
Direct effects of the nucleoside analogues on various other mitochondrial (and not only mitochondrial) targets causing metabolic dysfunction in cell culture must also be taken into account.
Of special interest is the observation that 2-SFLTTP showing a syn conformation around the glycosidic bond exerts lower inhibitory activity against pol ␥ than its 4-thio isomer and FLTTP, both in the anti conformation. 2-SFLTTP is also a more potent inhibitor of HIV-1 RT than 4-SFLTTP. In the same way, the parent nucleoside, 2-SFLT also showing a syn conformation, exhibits more potent in vitro activity against HIV-1, and shows a higher selectivity index than its 4-thio isomer in the anti conformation. Moreover, the selectivity index of 2-SFLT is 4-fold higher than that of FLT, which indicates that 2-SFLT is a potent and selective in vitro anti-HIV-1 agent.
